Fig. 4From: A novel approach to monitoring the efficacy of anti-tumor treatments in animal models: combining functional MRI and texture analysisImmunohistochemical results (× 200) with CD31 and VEGF stains of control, paclitaxel- and combination-treated tumors after 15 days of treatment. The target substances were dyed brownish yellow. Both microvessel density (MVD) assessed by CD31 and the optical density of VEGF were obviously lower in the combination therapy group than in the other two groupsBack to article page